Aspergillosis Clinical Trials in London
2 recruitingLondon, United Kingdom
Showing 1–2 of 2 trials
Recruiting
Phase 2
Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options
Chronic Pulmonary Aspergillosis
Mundipharma Research Limited60 enrolled37 locationsNCT06794554
Recruiting
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
Chronic Pulmonary Aspergillosis
Imperial College London100 enrolled3 locationsNCT06885905